돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 253813생성일: 2026년 10월 24일

4-(2-Chloroethyl)morpholine → 1-Cyclohexyl-3-[5-(2-morpholin-4-yl-ethylsulfanyl)-thiazol-2-yl]-1-[1-(thiophene-2-carbonyl)-piperidin-4-yl]-urea

https://huagongshe.com/ko/reaction/253813

반응식

참여 물질

역할이름HCID투입량
반응물4-(2-Chloroethyl)morpholineHCID 76727—
반응물DithioerythritolHCID 439352—
반응물4-[1-Cyclohexyl-3-(5-thiocyanato-thiazol-2-yl)-ureido]-piperidine-1-carboxylic acid tert-butyl esterHCID 86611188—
생성물1-Cyclohexyl-3-[5-(2-morpholin-4-yl-ethylsulfanyl)-thiazol-2-yl]-1-[1-(thiophene-2-carbonyl)-piperidin-4-yl]-ureaHCID 57883741—
생성물4-{1-Cyclohexyl-3-[5-(2-morpholin-4-yl-ethylsulfanyl)-thiazol-2-yl]-ureido}-piperidine-1-carboxylic acid tert-butyl esterHCID 86611191—

반응 단계

4-{1-Cyclohexyl-3-[5-(2-morpholin-4-yl-ethylsulfanyl)-thiazol-2-yl]-ureido}-piperidine-1-carboxylic acid tert-butyl ester was prepared as described in general procedure (H) and (I) using 4-[1-cyclohexyl-3-(5-thiocyanato-thiazol-2-yl)-ureido]-piperidine-1-carboxylic acid tert-butyl ester, dithioerythritol and N-(2-chloroethyl)-morpholine. Removal of the Boc group and N-acylation using thiophene-2 carboxylic acid as described in general procedure (G), steps 3 and 4 gave the title compound.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US07872139B2
출처 데이터셋uspto-grants-2011_01
ORD IDord-ea41a9ef9b034fc58ee11e818682ee46
출처 메모uspto-grants-2011_01